Clinical and Radiographic Evaluation of Crestal Bone Loss Around Implant With or Without Platform Switching Design
Launched by CAIRO UNIVERSITY · May 2, 2016
Trial Information
Current as of May 03, 2025
Completed
Keywords
ClinConnect Summary
The peri-implant bone level has been used as one of the criteria to assess the success of dental implants, Platform switching (PLS) for maintaining peri-implant bone levels has gained popularity among implant manufacturers over the last few years. However, the assumption that the inward shifting of the implant- abutment junction may preserve crestal bone was primarily based on serendipitous finding rather than scientific evidence.
It is known that saucerization around an implant occurs following abutment connection using a submerged implant with a butt joint (a two-stage approach), such as...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. Patients older than18 yrs.
- • 2. Patients with missing teeth in the posterior maxilla (from the 1st premolar to 2nd Molar) bilaterally in need for fixed implant-supported prosthesis.
- • 3. Full mouth plaque score and full mouth bleeding score ˂25 %
- • 4. Patients with adequate bone quality and quantity at the implant site
- • 5. Patients with systematic healthy.
- • 6. Non-smokers or those smoking ˂10 cigarettes/day
- • 7. Patients who were cooperative, motivated, and hygiene conscious and willing to return for multiple follow-up appointments (up to 9 months after prosthetic loading).
- Exclusion Criteria:
- • I) General:-
- • 1. Patients with any systemic condition that may contraindicate implant therapy.
- • 2. Patients with a history of Bisphosphonate therapy
- • 3. Pregnant and lactating patients
- • 4. Alcohol and drug abuse
- • 5. Parafunctional habits that produce overload on the implant such as bruxism and clenching.
- • II) Local:-
- • 1. Local inflammation or infection at implant site.
- • 2. Untreated periodontitis
- • 3. Local irradiation therapy
- • 4. History of implant failure as well as unhealed extraction socket
- • 5. Inadequate keratinized gingiva or thin gingival biotype.
- • 6. Inadequate bone height or width.
- • 7. Insufficient vertical inter-arch space, upon centric occlusion, to accommodate the available restorative components.
About Cairo University
Cairo University, a premier institution in Egypt, is dedicated to advancing medical research and education through innovative clinical trials. With a strong emphasis on improving healthcare outcomes, the university collaborates with various stakeholders to conduct rigorous scientific studies that address critical health challenges. Leveraging its extensive resources and expert faculty, Cairo University aims to contribute valuable insights to the medical community and enhance patient care both locally and globally. Through its commitment to ethical research practices and excellence, the university plays a pivotal role in shaping the future of healthcare in the region.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials